Muscarinic Receptors and Alzheimer's Disease: New Perspectives and Mechanisms

被引:2
|
作者
Monaco, Martina [1 ]
Trebesova, Hanna [1 ]
Grilli, Massimo [1 ,2 ]
机构
[1] Univ Genoa, Dept Pharm, Viale Cembrano 4, I-16148 Genoa, Italy
[2] Interuniv Ctr Promot 3Rs Principles Teaching & Res, I-16148 Genoa, Italy
关键词
Alzheimer's disease; muscarinic receptors; cholinergic transmission; neuroinflammation; innovative therapy; ACETYLCHOLINE-RECEPTOR; BINDING; DEFICITS; AGONIST; MEMORY; MODEL; NEUROINFLAMMATION; EXPRESSION; AROUSAL; PROTEIN;
D O I
10.3390/cimb46070407
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases on a global scale. Historically, this pathology has been linked to cholinergic transmission, and despite the scarcity of effective therapies, numerous alternative processes and targets have been proposed as potential avenues for comprehending this complex illness. Nevertheless, the fundamental pathophysiological mechanisms underpinning AD remain largely enigmatic, with a growing body of evidence advocating for the significance of muscarinic receptors in modulating the brain's capacity to adapt and generate new memories. This review summarizes the current state of the art in the field of muscarinic receptors' involvement in AD. A specific key factor was the relationship between comorbidity and the emergence of new mechanisms.
引用
收藏
页码:6820 / 6835
页数:16
相关论文
共 50 条
  • [31] Proven Therapies and new Perspectives for the Management of Alzheimer's Disease
    Ameri, Abdol A.
    NERVENHEILKUNDE, 2011, 30 (12) : 1013 - 1016
  • [32] Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimer's Disease
    Campillo, N. E.
    Paez, J. A.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (05) : 539 - 559
  • [33] MECHANISMS OF DISEASE Alzheimer's Disease
    Querfurth, Henry W.
    LaFerla, Frank M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (04): : 329 - 344
  • [34] Crosstalk between bone and brain in Alzheimer's disease: Mechanisms, applications, and perspectives
    Liu, Zhuo-Ting
    Liu, Ming-Han
    Xiong, Yan
    Wang, Yan-Jiang
    Bu, Xian-Le
    ALZHEIMERS & DEMENTIA, 2024, 20 (08) : 5720 - 5739
  • [35] Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer’s disease
    K. Nobuhara
    C. Halldin
    H. Hall
    P. Karlsson
    L. Farde
    J. Hiltunen
    D. W. McPherson
    A. Savonen
    K. A. Bergström
    S. Pauli
    C.-G. Swahn
    S. A. Larsson
    P.-O. Schnell
    G. Sedvall
    Psychopharmacology, 2000, 149 : 45 - 55
  • [36] New insights into mechanisms of psychosis in Alzheimer's disease.
    Sweet, RA
    Caligiuri, MP
    Pearlson, GD
    Pettegrew, JW
    Sultzer, D
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 10 (02): : 17 - 17
  • [37] Z-IQNP:: A potential radioligand for the SPECT study of muscarinic acetylcholine receptors in Alzheimer's disease
    Nobuhara, K
    Halldin, C
    Hall, H
    Karlsson, P
    Hiltunen, J
    McPherson, D
    Savonen, A
    Bergström, KA
    Swahn, CG
    Larsson, S
    Schnell, PO
    Farde, L
    Sedvall, G
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 973 - 973
  • [38] A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer's disease
    Kemp, PM
    Holmes, C
    Hoffmann, S
    Wilkinson, S
    Zivanovic, M
    Thom, J
    Bolt, L
    Fleming, J
    Wilkinson, DG
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (11): : 1567 - 1570
  • [39] G PROTEIN COUPLING OF GALANIN AND MUSCARINIC RECEPTORS IN POSTMORTEM BRAIN SLICES OF ALZHEIMER'S DISEASE PATIENTS
    Manuel, I.
    Barreda-Gomez, G.
    Giralt, M. T.
    Ferrer, I.
    Rodriguez-Puertas, R.
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2008, 30 : 91 - 91
  • [40] Z-IQNP:: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease
    Nobuhara, K
    Halldin, C
    Hall, H
    Karlsson, P
    Farde, L
    Hiltunen, J
    McPherson, DW
    Savonen, A
    Bergström, KA
    Pauli, S
    Swahn, CG
    Larsson, SA
    Schnell, PO
    Sedvall, G
    PSYCHOPHARMACOLOGY, 2000, 149 (01) : 45 - 55